Amphastar Pharmaceuticals, Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $73.3M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $29.0M | 39.5% |
| Stock Repurchases | $9.2M | 12.6% |
| Working Capital | $31.5M | 43.0% |
| Other | $3.6M | 4.9% |
| Net Cash Flow | $0 | 0.0% |
Net Cash Flow Breakdown
Total Cash from Operations: $73.3M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $29.0M | 39.5% |
| Stock Repurchases | $9.2M | 12.6% |
| Working Capital | $31.5M | 43.0% |
| Other | $3.6M | 4.9% |
| Net Cash Flow | $0 | 0.0% |